/
Qing-Xiang (Amy) Sang Chemistry and Qing-Xiang (Amy) Sang Chemistry and

Qing-Xiang (Amy) Sang Chemistry and - PowerPoint Presentation

eddey
eddey . @eddey
Follow
65 views
Uploaded On 2024-01-13

Qing-Xiang (Amy) Sang Chemistry and - PPT Presentation

Biochemistry qxsangchemfsuedu Biochemical Molecular and Pathological Mechanisms of Cancer Stroke Obesity and Stem Cell Differentiation and Cancer Biomarker and Drug Discovery for Precision ID: 1040487

medicine cancer human precision cancer medicine precision human obesity drug cell prognosis stem stroke biomarkers mechanisms molecular response chemotherapy

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "Qing-Xiang (Amy) Sang Chemistry and" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

1. Qing-Xiang (Amy) SangChemistry and Biochemistryqxsang@chem.fsu.eduBiochemical, Molecular, and Pathological Mechanisms of Cancer, Stroke, Obesity, and Stem Cell Differentiation, and Cancer Biomarker and Drug Discovery for Precision Medicine. Funded by NIH, DOD, Susan G. Komen Foundation, Florida DOH previously.Research on human breast cancer, prostate cancer, skin cancer, cancer health disparity, novel strategies for cancer chemotherapy, targeted therapy, and immunotherapy for precision medicine.We identify biomarkers for human cancer diagnosis, prognosis, treatment, and drug response for precision medicine, and biochemical mechanisms of inflammation, cancer, obesity, and stem cell formation.Dr. Sang’s lab is identifying novel human cancer biomarkers and mutational signatures for early cancer detection, chemotherapy, targeted therapy, and immunotherapy stratification, drug response, and prognosis for precision medicine to help patients with cancer, obesity, stroke, and inflammatory and cardiovascular diseases. We can offer biochemistry, molecular cell biology, and bioinformatics expertise for collaborative work on cancer, regenerative medicine, and precision medicine for multiple human disease models.